Thermostable Polymerase Aptamers for Reversible Hot-Start Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid synthesis assays using thermostable polymerases face issues with mispriming and non-specific product generation due to primer hybridization at lower temperatures, which can deplete reaction mixtures and mask the target product.

Innovation Solution

Development of aptamers that form a secondary structure to reversibly inhibit thermostable polymerases at lower temperatures, dissociating at optimal reaction temperatures to allow primer extension and target product generation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the assay is performed at lower or ambient temperature, then primer hybridization occurs more readily, but mispriming and non-specific product generation increase

Engineering Contradiction:
Improvespecificity of primer bindingVSAvoidmispriming and non-specific products
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by using an aptamer that pre-binds to the thermostable polymerase at ambient temperatures, preventing the polymerase from extending misprimed primers. The aptamer-polymerase complex is formed before the PCR reaction begins, and this complex actively prevents harmful mispriming events during the annealing step. Upon heating to the extension temperature, the aptamer releases the polymerase, allowing specific product amplification to proceed.

Inventive Principle:
Principle #9Preliminary anti-action

2Object-generated harmful factors

If chemical inhibitors are used to prevent mispriming, then non-specific product generation is reduced, but the reaction mixture composition becomes more complex

Engineering Contradiction:
Improvenon-specific productsVSAvoidreaction mixture composition
Core Design Contradiction:
Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

The patent employs an aptamer as an intermediary molecule that mediates between the polymerase and the primers. The aptamer serves as a reversible inhibitor that can be easily added to the reaction mixture without significantly altering its overall composition. The aptamer acts as a controllable switch: bound to polymerase at low temperatures to prevent mispriming, and released at high temperatures to allow specific amplification, thereby reducing non-specific products without complicating the reaction mixture.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If the polymerase is actively present at lower temperatures, then primer extension can occur, but non-specific amplification is generated

Engineering Contradiction:
Improveprimer extension efficiencyVSAvoidamplification specificity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies dynamics by making the polymerase activity dynamically controllable through temperature-dependent aptamer binding. At ambient temperatures, the aptamer is bound to the polymerase, dynamically suppressing its activity and preventing non-specific amplification. When the temperature is raised to the extension temperature, the aptamer dynamically releases the polymerase, enabling efficient and specific primer extension. This dynamic control allows the same polymerase to serve both protective and productive functions at different stages of the PCR cycle.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS12385045B2Thermostable polymerase inhibitor compositions and methods
Publication Date: 2025.08.12 CEPHEID INC
  • US12385045B2 patent drawing
  • US12385045B2 patent drawing
  • US12385045B2 patent drawing

AI summary

The present disclosure relates to aptamers for temperature-dependent reversible inhibition of thermostable polymerase activity in order to improve sensitivity and specificity of various reactions and assays involving hot start polynucleotide synthesis. Methods for use of the aptamers and related compositions and kits are also provided.